[EN] OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF REPERFUSION INJURY<br/>[FR] OXABICYCLOHEPTANES ET OXABICYCLOHEPTÈNES POUR LE TRAITEMENT D'UNE LÉSION DE REPERFUSION
申请人:LIXTE BIOTECHNOLOGY INC
公开号:WO2014005080A1
公开(公告)日:2014-01-03
A method of reducing reperfusion injury in mammalian tissue comprising contacting the tissue with a protein phosphatase 2A (PP2A) inhibitor having the structure.